Piyachaturawat Panida, Siramolpiwat Sith, Sonsiri Kanokwan, Tangkijvanich Pisit, Treeprasertsuk Sombat
Department of Medicine, Faculty of Medicine Chulalongkorn University Bangkok Thailand.
Gastroenterology Unit, Faculty of Medicine Chulalongkorn University Bangkok Thailand.
JGH Open. 2018 Jul 5;2(5):172-177. doi: 10.1002/jgh3.12063. eCollection 2018 Oct.
A nonselective B-blocker (NSBB) is recommended for primary prophylaxis of variceal bleeding. The impact of treatment with NSBB on modulating transient elastography (TE) has not been reported. The aim of the study is to investigate the effect of NSBB treatment on TE in early cirrhotic patients.
In this prospective study, we enrolled all early cirrhotic patients who underwent esophagogastroduodenoscopy (EGD) and showed small esophageal varices (EV) at our institute for a period of 1 year. The TE and heart rate (HR) of all participants were measured before and 3 months after receiving NSBB.
Thirty-nine patients receiving propanolol for 3 months were analyzed. There were 16 patients in the HR responder group (41%) and 23 patients in the HR nonresponder group (59%). The reduction of TE was preferably found in the HR responder group compared with the HR nonresponder group, in which mean changes in TE were -5.6 and -0.7 kPa, respectively ( = 0.23). In addition, we categorized the patients using their TE responses. Twenty-five patients (64.1%) showed reduced TE during the follow-up period, in which the mean TE value change was -2.94 kPa. Using correlation analysis, TE and HR responses were insignificantly correlated ( = 0.23, = 0.15).
The NSBB administered for 3 months mainly improved TE value in early cirrhotic patients even though the changes of HR and TE did not correlate. Further study is needed to confirm whether the monitoring of TE change may be a better predictor for pharmacological response than the HR response.
推荐使用非选择性β受体阻滞剂(NSBB)进行静脉曲张出血的一级预防。NSBB治疗对调制瞬时弹性成像(TE)的影响尚未见报道。本研究旨在探讨NSBB治疗对早期肝硬化患者TE的影响。
在这项前瞻性研究中,我们纳入了我院1年内接受食管胃十二指肠镜检查(EGD)且显示有小食管静脉曲张(EV)的所有早期肝硬化患者。在所有参与者接受NSBB治疗前及治疗3个月后测量其TE和心率(HR)。
分析了39例接受普萘洛尔治疗3个月的患者。HR反应者组有16例患者(41%),HR无反应者组有23例患者(59%)。与HR无反应者组相比,HR反应者组TE降低更明显,其中TE的平均变化分别为-5.6和-0.7kPa(P = 0.23)。此外,我们根据患者的TE反应对其进行分类。25例患者(64.1%)在随访期间TE降低,其中TE值的平均变化为-2.94kPa。通过相关性分析,TE和HR反应无显著相关性(P = 0.23,r = 0.15)。
尽管HR和TE的变化不相关,但给予NSBB治疗3个月主要改善了早期肝硬化患者的TE值。需要进一步研究以确认监测TE变化是否可能比HR反应是更好的药物反应预测指标。